The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,570.00
Bid: 1,550.00
Ask: 1,590.00
Change: -10.00 (-0.63%)
Spread: 40.00 (2.581%)
Open: 1,545.00
High: 1,570.00
Low: 1,545.00
Prev. Close: 1,580.00
CER Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

16 Oct 2023 07:00

RNS Number : 1520Q
Cerillion PLC
16 October 2023

AIM: CER

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

Cerillion plc

("Cerillion" or "the Company")

Trading Update and

Notice of Results and Capital Markets Event

Cerillion, the billing, charging and customer relationship management software solutions provider, is pleased to announce an update on trading for the financial year ended 30 September 2023.

After a very strong first six months, which set new records for revenue and adjusted pre-tax profit, Cerillion entered the second half of the financial year very well-placed, with both a strong back-order book* and buoyant sales pipeline. This positive trading picture has been maintained through the second half, including signing a £15.1 million new contract with an existing customer and completion of a major initial installation for Telesur, as announced in June and July respectively.

As a result of this continued strong progress, adjusted profit before tax is expected to be meaningfully ahead of the consensus market forecast of £14.3m. Revenue is expected to be approximately £39.0m, with sales to existing customers significantly greater than any previous year, reflecting the growing value of the installed base. Net cash at 30 September 2023 closed strongly at approximately £24.7m (30 September 2022: £20.2m).

As well as the demand the Company is experiencing from the existing customer base, the new customer sales pipeline grew again in the second half and includes some large opportunities. The Company therefore expects to make further encouraging progress over the course of the new financial year.

Notice of Results and Capital Markets Event

The Board intends to announce full year results in late November 2023, and will provide a further update on current trading at this point.

Cerillion will be hosting a Capital Markets Event for sell-side analysts and institutional investors on Tuesday, 28 November 2023 at 12.00pm. The event will feature presentations from senior management in marketing and product development within Cerillion as well as an opportunity for Q&A.

*Back-order book consists of sales contracted but not yet recognised as revenue at the end of the reporting period plus annualised support and maintenance revenue.

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Liberum (Nomad and Broker)

T: 020 3100 2000

Bidhi Bhoma, Ben Cryer, Matthew Hogg

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, George Tzimas, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

About Cerillion

www.cerillion.com

Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management ("CRM"), mainly serving the telecommunications market but also other sectors such as utilities and financial services. The Company currently has c.80 customer installations across c.44 countries. Headquartered in London, Cerillion also has operations in India, where its Global Solutions Centre is located, and in Bulgaria.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTGPGPAUUPWPUA
Date   Source Headline
22nd Apr 20247:00 amRNSTrading Update
13th Mar 20247:00 amRNSShare Purchase
13th Feb 20245:27 pmRNSTR-1 Notification
13th Feb 20245:22 pmRNSTR-1
1st Feb 20243:30 pmRNSResult of AGM
15th Dec 20234:15 pmRNSPosting of Annual Report and Notice of AGM
21st Nov 20235:34 pmRNSPDMR Shareholding
20th Nov 20237:00 amRNSFinal Results
17th Nov 20237:00 amRNSNotice of Results and Online Presentation
7th Nov 20237:00 amRNSLatest product release incorporates Generative AI
2nd Nov 20237:00 amRNSMajor new customer win with Tier-1 Telco
16th Oct 20237:00 amRNSTrading Update
25th Sep 202311:53 amRNSHolding(s) in Company
6th Jul 20237:00 amRNSCompletion of Initial Implementation at Telesur
21st Jun 20237:00 amRNSMajor new contract
22nd May 20237:00 amRNSGartner Market Guide Reports
15th May 20237:00 amRNSHalf-year Report
4th May 20237:00 amRNSDate of Interim Results and Investor Presentation
17th Apr 20237:00 amRNSH1 2023 Trading Update
31st Mar 20237:00 amRNSMajor New Contract
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:32 pmRNSHolding(s) in Company
21st Feb 20237:00 amRNSCompletion of Major Implementation
2nd Feb 20232:19 pmRNSResult of AGM
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSGrant of Options and PDMR Shareholding
15th Dec 20225:20 pmRNSHolding(s) in Company
2nd Dec 20222:35 pmRNSHolding(s) in Company
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.